8400 The Health Network
Shmulik Hess is an accomplished professional in the biotechnology and pharmaceutical sectors, currently serving as Chief Operating Officer and Chief Commercial Officer at MediWound since November 2023. Prior to this role, Shmulik co-founded and served as CEO of Tabby Therapeutics from May 2020 to November 2023 and held the position of CEO at Enlivex Therapeutics from November 2018 to December 2019, focusing on immunotherapy innovations. Shmulik's extensive experience also includes leadership roles at Valin Technologies, Active P, and a member of the executive board for ScienceAbroad. Educational qualifications include a PhD in Pharmaceutical Sciences from The Hebrew University of Jerusalem, alongside degrees in Emergency Medicine from Ben-Gurion University of the Negev.
This person is not in the org chart
This person is not in any teams
8400 The Health Network
On a mission to drive an Israeli economic growth engine in HealthTech and accelerate global cure, 8400 The Health Network is weaving a network of HealthTech ecosystem leaders, across silos and sectors, who learn together and create gap-closing projects that will propel a thriving HealthTech industry in Israel. The 8400 Fellowship runs annual cohorts of 60 senior Israeli leaders each, for an intensive 17 day program across 7 months. The program’s tailor-made curriculum is creating a continuous platform for breaking silos, peer learning and designing ecosystem growth initiatives. 8400 fellowship graduates join the 8400 Network.